[1] HOGARTH P M, PIETERSZ G A.Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond[J].Nature Reviews Drug Discovery, 2012, 11(4):311-331.DOI:10.1038/nrd2909. [2] STARBECKMILER G R, BADOVINAC V P, BARBER D L, et al.Expression of FcγRⅡb Tempers Memory CD8 T-cell Function in vivo[J].Journal of Immunology, 2013, 192(1):35-39.DOI:10.4049/jimmunol.1302232. [3] BOURNAZOS S, RAVETCH J V.Fcγ receptor function and the design of vaccination strategies[J].Immunity, 2017, 47(2):224-233.DOI:10.1016/j.immuni.2017.07.009. [4] ROGHANIAN A, STOPFORTH R J, DAHAL L N, et al.New revelations from an old receptor:Immunoregulatory functions of the inhibitory Fc gamma receptor, FcγRⅡb(CD32B)[J].Journal of Leukocyte Biology, 2018, 103(6):1077-1088.DOI:10.1002/jlb.2mir0917-354r. [5] MALBEC O, CASSARD L, ALBANESI M, et al.Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils[J].Science Signaling, 2016, 9(459):ra126.DOI:10.1126/scisignal.aag1401. [6] MALBEC O, ATTAL J P, FRIDMAN W H, et al.Negative regulation of mast cell proliferation by FcγRⅡb[J].Molecular immunology, 2002, 38(16/17/18):1295-1299.DOI:10.1016/s0161-5890(02)00078-0. [7] BAO D K, WANG R, QIAO S L, et al.Antibody-dependent enhancement of PRRSV infection down-modulates TNF-α and IFN-β transcription in macrophages[J].Veterinary Immunology and Immunopathology, 2013, 156(1/2):128-134.DOI:10.1016/j.vetimm.2013.09.006. [8] ESPELI M, SMITH K G C, CLATWORTHY M R.FcγRⅡb and autoimmunity[J].Immunological Reviews, 2016, 269(1):194-211.DOI:10.1111/imr.12368. [9] SONDERMANN P.The FcγR/IgG interaction as target for the treatment of autoimmune diseases[J].Journal of Clinical Immunology, 2016, 36(1):95-99.DOI:10.1007/s10875-016-0272-7. [10] HU X P, WU J Q, ZHU L P, et al.Association of Fcγ receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients[J].PLoS One, 2012, 7(8):e42439.DOI:10.1371/journal.pone.0042439. [11] KAY B K, KASANOV J, YAMABHAI M.Screening phage-displayed combinatorial peptide libraries[J].Methods, 2001, 24(3):240-246.DOI:10.1006/meth.2001.1185. [12] LOPES R S, QUEIROZ M A F, GOMES S T M, et al.Phage display:an important tool in the discovery of peptides with anti-HIV activity[J].Biotechnology Advances, 2018,36(7):1847-1854.DOI:10.1016/j.biotechadv.2018.07.003. [13] LISI S, SISTO M, LOFRUMENTO D D, et al.Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake[J].Clinical and Experimental Medicine, 2011, 11(1):1-10.DOI:10.1007/s10238-010-0098-1. [14] 张雷, 曹秀琴, 杨志伟.人可溶型FcγRⅡb的制备及其功能初步研究[J].细胞与分子免疫学杂志, 2012, 28(9):952-955.DOI:10.13423/j.cnki.cjcmi.006547. [15] 曹虹, 林琳, 刘北一,等.脑膜炎大肠杆菌IbeA蛋白结合肽序列的亲和筛选[J].微生物学通报, 2006, 33(5):101-106.DOI:10.3969/j.issn.0253-2654.2006.05.021. [16] MEULEMANS E V, SLOBBE R, WASTERVAL P, et al.Selection of phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody[J].Journal of Molecular Biology, 1994, 244(4):353-360.DOI:10.1006/jmbi.1994.1735. [17] 王祥卫, 郭应禄, 张立新, 等.人膀胱癌P-糖蛋白结合肽的筛选[J].中华泌尿外科杂志, 2003, 24(12):824-826.DOI:10.3760/j:issn:1000-6702.2003.12.010. [18] ZHANG F, WANG M, QIU Z, et al.Identification and characterization of strychnine-binding peptides using phage-display screening[J].Protein & Peptide Letters, 2017, 24(7):626-632.DOI:10.2174/0929866524666170404164408. |